Medical Innovation Exchange

Lilly 'won't be discouraged' if others fail in Alzheimer's, neuroscience chief says

https://www.fiercebiotech.com/biotech/lillys-alzheimers-drug-stacks-behind-biogen-eisais-fdas-priority-review-lane

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!